Blue Trust Inc’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,903
Closed -$1.21M 2738
2022
Q4
$1.21M Buy
4,903
+42
+0.9% +$14K 0.02% 162
2022
Q3
$1.2M Buy
4,861
+1,924
+66% +$520K 0.02% 140
2022
Q2
$973K Buy
+2,937
New +$793K 0.02% 141

Other funds holding ABMD

Blue Trust Inc's ABMD Position: Q1 2023 in Review

Blue Trust Inc sold out of Abiomed Inc (ABMD) in Q1 2023, closing a stake of 4,903 shares — an estimated $1.21M sold.

Blue Trust Inc first reported a position in ABMD in Q2 2022 and held it in 3 quarters. The position peaked at $1.21M in Q4 2022. 2 funds tracked by Wall St. Rank hold ABMD as of Q1 2023.

  • Blue Trust Inc reported no remaining Abiomed Inc position as of Q1 2023 after selling out during the quarter.
  • Blue Trust Inc sold 4,903 Abiomed Inc shares in Q1 2023, an estimated $1.21M.
  • Blue Trust Inc first reported a position in Abiomed Inc in Q2 2022 and held it in 3 quarters.
  • Blue Trust Inc's Abiomed Inc position peaked at $1.21M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2023.

Based on Blue Trust Inc's 13F filing for Q1 2023, filed 17 Apr 2023.